Form 4: Myomo CFO David Henry Acquires Shares Through Vesting of Performance-Based Restricted Stock Units

Myomo's Chief Financial Officer, David Henry, acquired 3,012 shares of common stock through the vesting of performance-based restricted stock units.

Summary

• David Henry, the Chief Financial Officer of Myomo, Inc., acquired 3,012 shares of common stock on June 9, 2024.
• These shares were obtained through the vesting of performance-based restricted stock units.
• The vesting was based on Myomo's stock price performance relative to a peer group from June 10, 2021, to March 9, 2024.
• The price of the shares at the time of vesting was $0.
• An additional 16,998 restricted stock units expired unvested.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction related to executive compensation. While the vesting of shares is positive, the expiration of other units is neutral. Overall, the sentiment is slightly positive but not significantly impactful.

Positives

• The vesting of performance-based restricted stock units indicates that the company met certain performance targets related to stock price performance.
• The acquisition of shares by the CFO aligns his interests with those of the shareholders.

Negatives

• The expiration of 16,998 restricted stock units suggests that the company did not meet all performance targets set for the vesting of these units.

Risks

• The vesting of shares based on stock price performance can be influenced by market conditions and may not always reflect the company's underlying performance.
• The expiration of a significant number of restricted stock units could potentially impact employee morale or future incentive plans.

Industry Context

This filing is a routine disclosure of insider transactions and is common for publicly traded companies. It reflects the compensation structure and performance-based incentives used by Myomo.

Comparison to Industry Standards

• The use of performance-based restricted stock units is a common practice in the technology and medical device industries to align executive compensation with company performance.
• Many companies, such as Insulet and Intuitive Surgical, use similar equity-based compensation plans.
• The vesting period of approximately 2.75 years is also typical for such grants.

Stakeholder Impact

• The vesting of shares may have a minor positive impact on shareholder sentiment as it indicates that the company met certain performance targets.
• The expiration of unvested units may have a minor negative impact on employee morale.

Key Dates

Keywords

Myomo, David Henry, restricted stock units, stock vesting, performance-based, insider trading, SEC Form 4, executive compensation